Akebia Therapeutics
AKBA
#7122
Rank
ยฃ0.31 B
Marketcap
ยฃ1.46
Share price
2.23%
Change (1 day)
53.99%
Change (1 year)

Akebia Therapeutics (AKBA) Fails to deliver data

Key failure to deliver metrics for Akebia Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Akebia Therapeutics (AKBA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Akebia Therapeutics (AKBA) - since 2014

Volume in USD (price x number of shares), data since 2014

Akebia Therapeutics (AKBA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024ยฃ4.8 M79.29%
2023ยฃ2.68 M-41.28%
2022ยฃ4.56 M8.92%
2021ยฃ4.19 M-18.58%
2020ยฃ5.15 M43.43%
2019ยฃ3.59 M-62.25%
2018ยฃ9.51 M238.71%
2017ยฃ2.8 M-25.14%
2016ยฃ3.75 M92.2%
2015ยฃ1.95 M-88.22%
2014ยฃ16.56 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
ยฃ62.92 Mยฃ0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ86.4 Mยฃ0.14 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ81.31 Mยฃ0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.03 Mยฃ0.16 M๐Ÿ‡บ๐Ÿ‡ธ USA